"В центъра се предлага пълен набор от медицински услуги: дейности по здравна промоция и профилактика на социално значими заболявания, включително профилактични прегледи и имунизации: - рак на млечна жлеза; - рак на простата; - увреждания на очния нерв - глаукомаизвършва експертизи за временната нетрудоспособност; Издава медицински свидетелства за постъпване на работа, здравни книжки, медицински свидетелства за управление на МПС; Насочва пациентите за консултативна и болнична помощ;осигурява висококвалифицирани изследвания и консултации във висши медицински заведения в срок от 24 часа;"

During the past decade, Medical Center-1-Sevlievo EOOD conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 13 clinical trials were completed, i.e. on average, 56.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 13 clinical trials were completed. i.e. 144.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Center-1-Sevlievo EOOD" #1 sponsor was "Pfizer" with 4 trials, followed by "Shire" with 3 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center-1-Sevlievo EOOD" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Medical Center-1-Sevlievo EOOD" are "Ulcerative Colitis" (6 trials), "Rheumatoid Arthritis" (5 trials), "Systemic Lupus Erythematosus" (4 trials), "COVID-19" (3 trials) and "Ankylosing Spondylitis" (1 trials). Many other conditions were trialed in "Medical Center-1-Sevlievo EOOD" in a lesser frequency.

Most popular intervention types in "Medical Center-1-Sevlievo EOOD" are "Drug" (21 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "GDC-0853" (2 trials), "Mesalamine" (2 trials), "Ontamalimab" (2 trials) and "PF-07321332" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center-1-Sevlievo EOOD" are 21 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Center-1-Sevlievo EOOD". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Medical Center-1-Sevlievo EOOD, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center-1-Sevlievo EOOD, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".